Transcatheter aortic valve replacement (TAVR) is a transformative innovation that provides
treatment for high or prohibitive surgical risk patients with symptomatic severe aortic stenosis …

Transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation
(TAVI) has emerged as an attractive treatment strategy for the treatment of patients with …

Indications for transcatheter aortic valve replacement (TAVR) have steadily increased over
the last decade since the first trials including inoperable or very high risk patients. Thus …

Transcatheter aortic valve replacement (TAVR) is approved for all patient risk profiles and is
an option for all patients irrespective of age. However, patients enrolled in the low-and …

Background: Randomized trials support the use of transcatheter aortic valve replacement
(TAVR) for the treatment of aortic stenosis in high-and intermediate-risk patients, but the …

Transcatheter aortic valve implantation (TAVI) has spawned the evolution of novel catheter-
based therapies for a variety of cardiovascular conditions. Newer device iterations are …

Background—Transcatheter aortic valve replacement (TAVR) is a less invasive option for
treatment of high-risk patients with severe aortic stenosis. We sought to identify patients at …

Transcatheter aortic valve implantation (TAVI) or replacement has rapidly changed the
treatment of patients with severe symptomatic aortic stenosis. It is now the standard of care …

Background—Transcatheter aortic valve replacement (TAVR) has emerged as a less
invasive option for valve replacement of patients with severe aortic stenosis. Although it has …

Transcatheter aortic valve replacement (TAVR) is an established treatment for severe,
symptomatic, aortic stenosis (AS) in patients of all risk categories and now comprises 12.5 …